+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Citeline - Market Research Reports

Citeline's analysis, insight and consultancy services span drug, device, company, clinical trial and market intelligence. All services are delivered by an authoritative team of industry experts in key markets around the globe.

CMS Actively Looking For New Reimbursement Pathway For Innovative Devices - Product Thumbnail Image

CMS Actively Looking For New Reimbursement Pathway For Innovative Devices

  • Newsletter
  • April 2024
  • 3 Pages
  • Global
From
Kratom Industry Offers Own Standards As Another Firm Warned About FDA Rules - Product Thumbnail Image

Kratom Industry Offers Own Standards As Another Firm Warned About FDA Rules

  • Newsletter
  • April 2024
  • 3 Pages
  • Global
From
The Case For CAR-T Grows As Responses Hold Up Longer Term - Product Thumbnail Image

The Case For CAR-T Grows As Responses Hold Up Longer Term

  • Newsletter
  • April 2024
  • 6 Pages
  • Global
From
Strategy At Novartis: Culture Change As The 'How' Behind The 'What' - Product Thumbnail Image

Strategy At Novartis: Culture Change As The 'How' Behind The 'What'

  • Newsletter
  • April 2024
  • 6 Pages
  • Global
From
116th Congress Could Test Cosmetic Industry's Commitment To Reg Reform, Preemption Viability - Product Thumbnail Image

116th Congress Could Test Cosmetic Industry's Commitment To Reg Reform, Preemption Viability

  • Newsletter
  • April 2024
  • 3 Pages
  • Global
From
GSK And Pfizer Start Consumer JV For Different Reasons, Aim For Similar Goals - Product Thumbnail Image

GSK And Pfizer Start Consumer JV For Different Reasons, Aim For Similar Goals

  • Newsletter
  • April 2024
  • 4 Pages
  • Global
From
Real-World Evidence: US FDA's Prucalopride Review Shows Datasets' Utility And Limitations - Product Thumbnail Image

Real-World Evidence: US FDA's Prucalopride Review Shows Datasets' Utility And Limitations

  • Newsletter
  • April 2024
  • 4 Pages
  • United States
From
Part B Payment Model Indexing Commercial Discounts Proposed By Genentech - Product Thumbnail Image

Part B Payment Model Indexing Commercial Discounts Proposed By Genentech

  • Newsletter
  • April 2024
  • 3 Pages
  • Global
From
Schleifer, Yancopoulos And The $36 Billion Friendship - Product Thumbnail Image

Schleifer, Yancopoulos And The $36 Billion Friendship

  • Newsletter
  • April 2024
  • 4 Pages
  • Global
From
Neuroscience Is The Next Oncology: Why Biogen Is Doubling Down - Product Thumbnail Image

Neuroscience Is The Next Oncology: Why Biogen Is Doubling Down

  • Newsletter
  • April 2024
  • 5 Pages
  • Global
From
Investigator Horror Stories 3: Boozing On The Job? Yup, That Happened - As Have These Other Shocking Tales Of Irregular FDA Inspections - Product Thumbnail Image

Investigator Horror Stories 3: Boozing On The Job? Yup, That Happened - As Have These Other Shocking Tales Of Irregular FDA Inspections

  • Newsletter
  • April 2024
  • 5 Pages
  • Global
From
Accenture Prescribes A New Data Management Future For Medtechs - Product Thumbnail Image

Accenture Prescribes A New Data Management Future For Medtechs

  • Newsletter
  • April 2024
  • 5 Pages
  • Global
From
EMA To Re-Prioritize Tasks To Cope With 'Higher Than Expected' Staff Losses - Product Thumbnail Image

EMA To Re-Prioritize Tasks To Cope With 'Higher Than Expected' Staff Losses

  • Newsletter
  • April 2024
  • 3 Pages
  • Global
From
Next-Generation Roche: How Data Analytics Will Keep It In The Lead In Oncology - Product Thumbnail Image

Next-Generation Roche: How Data Analytics Will Keep It In The Lead In Oncology

  • Newsletter
  • April 2024
  • 4 Pages
  • Global
From
US FDA May Largely Avoid House Democrats' Investigation Agenda - Product Thumbnail Image

US FDA May Largely Avoid House Democrats' Investigation Agenda

  • Newsletter
  • April 2024
  • 3 Pages
  • United States
From
FDA Plans Consumer Survey To Better Understand Cosmetics Allergy Prevalence - Product Thumbnail Image

FDA Plans Consumer Survey To Better Understand Cosmetics Allergy Prevalence

  • Newsletter
  • April 2024
  • 3 Pages
  • Global
From
J&J Scores Early In 'Hypoallergenic' Case; Plaintiff's Definition 'Implausible,' Court Says - Product Thumbnail Image

J&J Scores Early In 'Hypoallergenic' Case; Plaintiff's Definition 'Implausible,' Court Says

  • Newsletter
  • April 2024
  • 3 Pages
  • Global
From
What Do Cosmetics Reform Campaigners Dream Of At Night? Rep. Schakowsky Just Reintroduced It - Product Thumbnail Image

What Do Cosmetics Reform Campaigners Dream Of At Night? Rep. Schakowsky Just Reintroduced It

  • Newsletter
  • April 2024
  • 3 Pages
  • Global
From
Bayer's US Playbook: The Smart Way To Top-Line Growth - Product Thumbnail Image

Bayer's US Playbook: The Smart Way To Top-Line Growth

  • Newsletter
  • April 2024
  • 7 Pages
  • United States
From
Novartis Pruned Pipeline Producing Attractive Respiratory And Neurology Fruits - Product Thumbnail Image

Novartis Pruned Pipeline Producing Attractive Respiratory And Neurology Fruits

  • Newsletter
  • April 2024
  • 6 Pages
  • Global
From
Loading Indicator